Secure Delivery of HIV-Related and Tuberculosis Laboratory Results to Patient Cell Phones: A Pilot Comparative Study

  • PDF / 932,155 Bytes
  • 11 Pages / 595.276 x 790.866 pts Page_size
  • 101 Downloads / 156 Views

DOWNLOAD

REPORT


ORIGINAL PAPER

Secure Delivery of HIV‑Related and Tuberculosis Laboratory Results to Patient Cell Phones: A Pilot Comparative Study Lisa DiAndreth1,2 · Brooke A. Jarrett2,9 · Jessica L. Elf3 · Thamanna Nishath2 · Brennan Donville4 · Omeid Heidari1 · Sarah Cox2 · Justine Moreton5 · Aveer Ramnath5 · Limakatso Lebina6 · Ebrahim Variava6,7 · Jonathan E. Golub2,8 · Neil A. Martinson6,7,8

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Abstract South Africa processes 5.1 million HIV CD4, viral load (VL), and tuberculosis (TB) tests annually. This pilot non-randomized trial in South Africa explored an intervention (“MatlaMobile”) to deliver laboratory results via mobile phone. Adults completing CD4, VL, and/or TB laboratory tests were enrolled—either receiving results by returning to clinic (control, n = 174) or mobile phone (intervention, n = 226). Study staff instructed control participants to return within 6 days (standard-of-care). MatlaMobile instructed intervention participants with clinically actionable results requiring intervention or treatment change (i.e.,